Valery Rostislavovich Polyakov

Title: Valery Rostislavovich Polyakov: Innovator in Kinase Inhibitors

Introduction

Valery Rostislavovich Polyakov is a notable inventor based in Moraga, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. With a total of five patents to his name, Polyakov's work has the potential to impact the treatment of various disorders.

Latest Patents

Polyakov's latest patents include innovative compounds designed to inhibit Raf kinase activity. One of his notable inventions is titled "Biaryl amide compounds as kinase inhibitors." This invention provides compounds of Formula (I) and their salts, along with therapeutic uses for treating disorders associated with Raf kinase activity. Additionally, he has developed another patent titled "Compounds and compositions as kinase inhibitors," which also focuses on compounds of Formula (I) and (II) for similar therapeutic applications.

Career Highlights

Valery Polyakov is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further his research and development in the field of kinase inhibitors, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Polyakov has collaborated with esteemed colleagues, including Paul Andrew Barsanti and Matthew T Burger. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Valery Rostislavovich Polyakov is a distinguished inventor whose work in kinase inhibitors is paving the way for new therapeutic options. His contributions to the field are significant and continue to influence the pharmaceutical industry.